Bryan J. McMichael - Mar 27, 2023 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role: Title: Executive Vice President, Accounting, Corporate Controller and Principal Accounting Officer
Signature: /s/ McDavid Stilwell, as Attorney-in-Fact for Bryan J. McMichael
Stock symbol: CHRS
Transactions as of: Mar 27, 2023
Transactions value $: $0
Form type: 4
Date filed: 3/29/2023, 04:30 PM
Previous filing: Jan 24, 2023
Next filing: Jun 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CHRS	Stock Option (Right to Buy)	Award	$0	+25K		$0.00	25K	Mar 27, 2023	Common Stock	25K	$6.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1. The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from March 27, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Remarks:

Title: Executive Vice President, Accounting, Corporate Controller and Principal Accounting Officer